Astragaloside IV Stimulates Angiogenesis and Increases Hypoxia-Inducible Factor-1α Accumulation via Phosphatidylinositol 3-Kinase/Akt Pathway
Open Access
- 16 May 2011
- journal article
- research article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in The Journal of pharmacology and experimental therapeutics
- Vol. 338 (2), 485-491
- https://doi.org/10.1124/jpet.111.180992
Abstract
Astragaloside IV is the major active constituent of Astragalus membranaceus, which has been widely used for the treatment of cardiovascular diseases in China. The aim of this study was to determine the angiogenic effect of astragaloside IV and its underlying mechanism. We used the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide assay, Western blotting, real-time polymerase chain reaction, and immunofluorescence to detect the effect of astragaloside IV on proliferation of human umbilical vein endothelial cells (HUVECs), the phospho-Akt protein level, hypoxia-inducible factor-1α (HIF-1α) accumulation, vascular endothelial growth factor mRNA expression, and applied cell migration, tube formation, and chick chorioallantoic membrane assays to study the angiogenic effect of astragaloside IV. Results indicate that astragaloside IV promoted cell proliferation and stimulated HIF-1α accumulation during hypoxia. Mechanism studies revealed that astragaloside IV did not affect the degradation of HIF-1α protein or the level of HIF-1α mRNA. In contrast, astragaloside IV apparently activated the phosphatidylinositol 3-kinase (PI3K)/Akt pathway, which regulates HIF-1α protein synthesis. Moreover, astragaloside IV also stimulated cell migration, increased tube formation, and promoted angiogenesis in the chick chorioallantoic membrane assay. All angiogenic effects of astragaloside IV were reversed by the PI3K inhibitor. Taken together, our data collectively reveal that astragaloside IV is a novel regulator of HIF-1α and angiogenesis through the PI3K/Akt pathway in HUVECs that are exposed to hypoxia.This publication has 24 references indexed in Scilit:
- Carbon Monoxide Promotes VEGF Expression by Increasing HIF-1α Protein Level via Two Distinct Mechanisms, Translational Activation and Stabilization of HIF-1α ProteinOnline Journal of Public Health Informatics, 2010
- PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell linesCancer Letters, 2009
- MFTZ-1 reduces constitutive and inducible HIF-1α accumulation and VEGF secretion independent of its topoisomerase II inhibitionJournal of Cellular and Molecular Medicine, 2009
- Role of PI3K/Akt and MEK/ERK in Mediating Hypoxia-Induced Expression of HIF-1 and VEGF in Laser-Induced Rat Choroidal NeovascularizationInvestigative Ophthalmology & Visual Science, 2009
- Identification of small molecule compounds that inhibit the HIF-1 signaling pathwayMolecular Cancer, 2009
- PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesisCellular Signalling, 2007
- Protein kinase C promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factorCardiovascular Research, 2007
- Myocardial Angiogenesis: Its Absence Makes the Growing Heart FounderCell Metabolism, 2007
- Astragaloside IV Dilates Aortic Vessels from Normal and Spontaneously Hypertensive Rats through Endothelium-Dependent and Endothelium-Independent WaysPlanta Medica, 2006
- Effects of Phytoestrogens Genistein and Daidzein on Prostacyclin Production by Human Endothelial CellsThe Journal of pharmacology and experimental therapeutics, 2005